When Might Rexulti Become Available as a Generic?
The availability of a generic version of Rexulti (brexpiprazole) is currently tied to patent protections and potential legal challenges. While it is anticipated that a generic could become available around 2026, this date is subject to change based on ongoing patent disputes.
What Are the Key Patents for Rexulti?
Rexulti's primary patent is U.S. Patent No. 8,815,858, which covers the active pharmaceutical ingredient brexpiprazole. This patent is listed in the FDA's Orange Book [1]. DrugPatentWatch.com tracks these patents, providing detailed information on their expiration dates and any associated litigation [2].
Why Might Generic Availability Be Delayed or Accelerated?
Patent litigation is a significant factor influencing generic drug timelines. If patent challenges are successful, it could lead to an earlier release of generic Rexulti. Conversely, if patents are upheld or extended, the generic launch could be pushed back. The outcome of legal proceedings plays a crucial role in determining the exact generic availability date.
Can Biosimilars or Other Generics Enter the Market Before Patent Expiry?
While this query specifically pertains to generic availability, it's important to distinguish between generics and biosimilars. Generics are for small-molecule drugs like Rexulti, while biosimilars are for biologic drugs. The development and approval pathways for each are different. For Rexulti, the focus is on generic versions of the brexpiprazole active ingredient.
Who Manufactures Rexulti and Potential Generic Versions?
Rexulti is manufactured by Otsuka Pharmaceutical Co., Ltd. and Lundbeck [3]. Generic manufacturers will aim to produce their own versions of brexpiprazole once patent exclusivity allows.
What Clinical Data Supports Rexulti's Efficacy?
Rexulti is approved for the treatment of schizophrenia and as an adjunctive treatment for major depressive disorder [3]. Its efficacy in these indications is supported by clinical trials that have been reviewed by regulatory agencies.
What Are Patient Concerns Regarding Rexulti?
Patients often inquire about the side effects and overall tolerability of medications. Common side effects of Rexulti can include akathisia, weight gain, and somnolence [3]. Discussions around these potential adverse events are typical for any prescription medication.
What is the Current Pricing of Rexulti?
As a branded pharmaceutical, Rexulti's pricing is set by the manufacturer. Generic versions, once available, are typically priced at a significant discount compared to the brand-name drug.
---
Sources:
[1] U.S. Food & Drug Administration. (n.d.). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Retrieved from https://www.accessdata.fda.gov/scripts/cder/ob/
[2] DrugPatentWatch.com. (n.d.). Rexulti. Retrieved from https://drugpatentwatch.com/
[3] Otsuka Pharmaceutical Co., Ltd. & Lundbeck. (n.d.). Rexulti® (brexpiprazole). Retrieved from https://www.rexulti.com/